ATE370741T1 - Verwendung eines inhibitors eines kostimulatorischen vorgangs des immunsystems zur herstellung eines medikaments zum schutz transplantierter, nichtembryonaler lebender zellen vor zerstörung durch das immunsystem - Google Patents

Verwendung eines inhibitors eines kostimulatorischen vorgangs des immunsystems zur herstellung eines medikaments zum schutz transplantierter, nichtembryonaler lebender zellen vor zerstörung durch das immunsystem

Info

Publication number
ATE370741T1
ATE370741T1 AT96936037T AT96936037T ATE370741T1 AT E370741 T1 ATE370741 T1 AT E370741T1 AT 96936037 T AT96936037 T AT 96936037T AT 96936037 T AT96936037 T AT 96936037T AT E370741 T1 ATE370741 T1 AT E370741T1
Authority
AT
Austria
Prior art keywords
immune system
embryona
medication
destruction
inhibitor
Prior art date
Application number
AT96936037T
Other languages
English (en)
Inventor
Collin Weber
Mary Hagler
Peter Linsley
Judith Kapp
Original Assignee
Univ Emory
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Emory, Bristol Myers Squibb Co filed Critical Univ Emory
Application granted granted Critical
Publication of ATE370741T1 publication Critical patent/ATE370741T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A61K2035/128—Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT96936037T 1995-09-27 1996-09-27 Verwendung eines inhibitors eines kostimulatorischen vorgangs des immunsystems zur herstellung eines medikaments zum schutz transplantierter, nichtembryonaler lebender zellen vor zerstörung durch das immunsystem ATE370741T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60437595A 1995-09-27 1995-09-27

Publications (1)

Publication Number Publication Date
ATE370741T1 true ATE370741T1 (de) 2007-09-15

Family

ID=38284026

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96936037T ATE370741T1 (de) 1995-09-27 1996-09-27 Verwendung eines inhibitors eines kostimulatorischen vorgangs des immunsystems zur herstellung eines medikaments zum schutz transplantierter, nichtembryonaler lebender zellen vor zerstörung durch das immunsystem

Country Status (3)

Country Link
EP (1) EP0877555B1 (de)
AT (1) ATE370741T1 (de)
DE (1) DE69637216D1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140112958A1 (en) 2012-10-24 2014-04-24 Mwm Biomodels Gmbh Pancreatic islets of transgenic LEA29Y animals for treating diabetes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO166836C (no) * 1985-03-14 1991-09-11 Univ California Fremgangsmaate for behandling av et organtransplantat.
US5334640A (en) * 1992-04-08 1994-08-02 Clover Consolidated, Ltd. Ionically covalently crosslinked and crosslinkable biocompatible encapsulation compositions and methods

Also Published As

Publication number Publication date
EP0877555A1 (de) 1998-11-18
EP0877555A4 (de) 2000-12-20
EP0877555B1 (de) 2007-08-22
DE69637216D1 (de) 2007-10-04

Similar Documents

Publication Publication Date Title
DE69021960D1 (de) Verfahren zur kontinuierlichen Herstellung von einem grossflächigen funktionellen aufgedampften Film mittels Mikrowellen-Plasma-CVD sowie Anlage zur Durchführung des Verfahrens.
DE59004931D1 (de) Verfahren zur Herstellung intumeszenzfähiger Formteile.
NO20050408L (no) Nye camptothecinderivater (CPT-11) og beslektede forbindelser, samt fremgangsmate for fremstilling derav
DE69329303D1 (de) Verfahren zur Herstellung eines diffusionsgebundenen Sputtertargetaufbaus
DE59100508D1 (de) Verfahren zur Herstellung aktiver, reversibel H2 aufnehmender Magnesiumhydrid-Magnesium-Wasserstoff-Speichersysteme.
DE69609244D1 (de) Verfahren zur Herstellung diamantartiger Beschichtungen
DE69603132D1 (de) Verfahren zur Herstellung von Kernbrennstofftabletten auf Basis von (U,PU)02 unter Zugabe von organischen Zwitterion-Schwefelverbindungen
DE69620847D1 (de) Verfahren zur Herstellung einer alpha-Hydroxy-säure oder eines alpha-Hydroxy-amids mittels Mikroorganismen
AT380471B (de) Verfahren zur herstellung von neuen 2-oxoazetidin-derivate
NO980299L (no) Cytokinproduksjonsinhibitorer, preparater derav og deres anvendelse i medisin, samt fremgangsmåter for deres identifikasjon
DE68924453D1 (de) Verfahren zur Herstellung eines Polyisocyanats.
DE69126298D1 (de) Verfahren zur Herstellung optisch aktiven (R)-1,3-Butanediols mittels eines Mikroorganismus der Gattung Rhodococcus
ATE279424T1 (de) Neue verbindungen kf-1040 und verfahren zu ihrer herstellung
ATE370741T1 (de) Verwendung eines inhibitors eines kostimulatorischen vorgangs des immunsystems zur herstellung eines medikaments zum schutz transplantierter, nichtembryonaler lebender zellen vor zerstörung durch das immunsystem
DE68922147D1 (de) Verfahren zur Herstellung eines Kautschuklaminats.
DE69228534D1 (de) Verfahren zur Herstellung hochmolekularer Polycarbonate
ATE232387T1 (de) Verwendung eines inositoltriphosphatester, zur herstellung eines medikamentes
ATA373284A (de) Verfahren zur herstellung von neuem, kristallinem cephalexinhydrochloridmonohydrat und dessen verwendung zur herstellung eines arzneimittels
DE68917642D1 (de) Verfahren zur kontinuierlichen Züchtung von haftenden tierischen Zellen.
DE68923534D1 (de) Verfahren zur Herstellung eines organischen Kristalls.
ATE216235T1 (de) Verwendung von cholinesterase-inhibitoren für die herstellung eines medikaments zur behandlung von xerostomie
DE69412645D1 (de) Herstellung eines makromanomers
DE69632677D1 (de) Verwendung eines Rifamycin-Derivates zur Herstellung eines Medikamentes zur Behandlung von Krankheiten verursacht durch Helicobacter pylori-Infektionen
DE59603661D1 (de) Verfahren zur Herstellung von Polyisoolefinen mittels neuer Initiatorsysteme
DE69905208D1 (de) Kontinuierliches Verfahren zur Herstellung von Polyvinylacetat zum Herstellen von Polyvinylalkohol

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties